Welcome to our dedicated page for Agilent Technologies SEC filings (Ticker: A), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Agilent Technologies Inc. (NYSE: A) SEC filings page provides access to the company’s official regulatory disclosures filed with the U.S. Securities and Exchange Commission. These documents include current reports on Form 8-K, annual and quarterly reports when available, and other filings that describe Agilent’s financial condition, governance changes, and capital markets activities.
Agilent uses Form 8-K to report material events such as quarterly financial results and executive leadership changes. For example, the company has filed 8-Ks to furnish earnings press releases for fiscal quarters, explaining revenue, net income, segment performance for the Life Sciences and Diagnostics Markets Group, Agilent CrossLab Group, and Applied Markets Group, and to discuss the use of non-GAAP financial measures. Separate 8-K filings describe the resignation of a chief financial officer, the appointment of an interim CFO, and the subsequent appointment of a new senior vice president and chief financial officer, including related compensation and equity awards.
Through its filings, Agilent explains why it presents non-GAAP financial information, stating that these measures are intended to provide meaningful supplemental insight into operational performance and to facilitate comparisons with historical results and other companies. The company notes that non-GAAP figures exclude items such as restructuring and amortization, are monitored alongside GAAP results, and may differ from similar measures used by other issuers.
On Stock Titan, these SEC filings are updated from EDGAR and can be paired with AI-powered summaries that highlight key points, such as changes in leadership, segment trends, and the rationale behind non-GAAP adjustments. Users can quickly locate current reports, review disclosures about executive appointments and compensation arrangements, and understand how Agilent communicates its financial performance and governance decisions to regulators and investors.
The Vanguard Group filed Amendment No. 13 to a Schedule 13G/A reporting 0% ownership in Agilent Technologies Inc. (Common Stock). The filing states that, following an internal realignment on January 12, 2026, certain Vanguard subsidiaries will report holdings separately and Vanguard no longer is deemed to beneficially own those securities. The form lists Amount beneficially owned: 0 and is signed on 03/26/2026.
Rataj Sue H. reported acquisition or exercise transactions in this Form 4 filing.
AGILENT TECHNOLOGIES, INC. director Sue H. Rataj received an award of 2,158 shares of common stock on March 19, 2026. The shares were granted as compensation for service as a non-employee director and were fully vested upon grant at a reference price of $111.75 per share. Following this award, she directly holds 23,617 shares of Agilent common stock.
Agilent Technologies director Otis W. Brawley received two awards of common stock on March 19, 2026, acquiring 2,158 and 888 shares as compensation grants at a reference price of $111.75 per share. These are non-employee director awards that are fully vested upon grant.
According to the footnotes, Brawley elected to defer receipt of these shares into a deferral account under Agilent’s deferred compensation arrangements, rather than taking the stock immediately. After these transactions, his directly held and deferred Agilent common stock position reported in this filing totals 13,873.623 shares.
AGILENT TECHNOLOGIES, INC. director George A. Scangos reported equity awards of common stock. On 2026-03-19, he received two grants of Agilent common stock as a non-employee director, covering 2,158 shares and 1,057 shares at a reference price of $111.75 per share.
The awards are fully vested upon grant, and he has elected to defer receipt of these shares into a deferral account under Agilent’s 2005 Deferred Compensation Plan for Non-Employee Directors. A footnote also states that 148.973 shares were acquired through Agilent’s dividend reinvestment plan and likewise deferred.
After these transactions, Scangos holds 23,857.047 Agilent shares directly in deferred accounts and an additional 17,893 shares indirectly through the George A. Scangos and Leslie S. Wilson Family Trust. These transactions reflect compensation and deferral elections rather than open-market buying or selling.
Agilent Technologies director Pascal Soriot reported a routine equity compensation event. He received 2,158 shares of Agilent common stock as a fully vested stock award for non-employee directors at a reference price of $111.75 per share. To cover tax obligations on the vesting of restricted stock units, he surrendered 648 shares back to Agilent under Rule 16b-3, a tax-withholding disposition rather than a market sale. After these transactions, he directly holds 2,683 shares of Agilent common stock.
Agilent Technologies director Wilson Dow reported receiving an award of 2,158 shares of common stock on March 19, 2026 at a reference price of $111.75 per share. This was a fully vested stock grant for non-employee directors, classified as a compensation-related acquisition rather than an open-market purchase.
After the award, Dow directly holds 20,368.606 shares of Agilent common stock. A footnote also states that 144.124 shares were acquired through the company’s dividend reinvestment plan and have been deferred by the reporting person.
Podolsky Daniel K reported acquisition or exercise transactions in this Form 4 filing.
Agilent Technologies director Daniel K. Podolsky received a grant of 2,158 shares of common stock valued at $111.75 per share. The award was made as compensation for non-employee directors and is fully vested upon grant. Podolsky elected to defer receipt of these shares, meaning delivery is postponed under Agilent’s deferral arrangements.
Following this award and prior dividend reinvestment activity noted in the footnotes, Podolsky now holds 38,179.908 shares of Agilent common stock in total.
Agilent Technologies director Koh Boon Hwee received an award of 2,158 shares of common stock valued at $111.75 per share as compensation for non-employee directors, fully vested upon grant. In connection with this award and vesting of restricted stock units, he surrendered 648 shares to Agilent to cover tax liabilities.
Footnotes note an additional 106.132 shares acquired through the dividend reinvestment plan, which he has elected to defer. After these transactions, Koh directly holds 63,184.351 shares of Agilent common stock.
Agilent Technologies director Mikael Dolsten received a stock award, increasing his holdings. He was granted 2,158 shares of Agilent common stock at a value of $111.75 per share as a fully vested award for non-employee directors. Following the grant, he directly holds 7,138.2100 shares of common stock. Dolsten elected to defer receipt of 1,079 of the granted shares, and an additional 7.182 shares were acquired and deferred through the company’s dividend reinvestment plan.
Agilent Technologies director Judy L. Brown received a stock award of 2,158 shares of common stock on March 19, 2026. The award for non-employee directors is fully vested upon grant and was valued at $111.75 per share. Following this grant, Brown directly owns 3,835 Agilent shares. This is a compensation-related share acquisition rather than an open-market purchase.